Buy Orchid Chemicals & Pharmaceuticals Ltd.
Price target: Rs184 CM Price: Rs163.30
Event
- Orchid Chemicals & Pharmaceuticals (Orchid) has received US Food and Drug Administration (USFDA)’s approval to sell its much-awaited Tazo-Pip, a premium life-saving antibiotic injection, in the US market.This is the first generic to be approved with Orchid receiving a 180-day exclusivity.
- Orchid would be immediately launching this product in marketing and distribution partnership with Apotex in the USA. The company received approval for selling Tazo-Pip in the USA in H2FY2010 in line with our assumption, however the 180- day exclusivity is a positive surprise.
Implication